Manipulation of the microbiota using probiotics

Advances in Experimental Medicine and Biology

Volumn 902, Issue , 2016, Pages 109-117

  Grimm, Verena ^a   Riedel, Christian U ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Allergy; Diarrhea; IBD; IBS; Necrotising enterocolitis

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; PROBIOTIC AGENT; TOLL LIKE RECEPTOR 4;

ALLERGIC DISEASE; ATOPIC DERMATITIS; ATOPY; CLINICAL FEATURE; CROHN DISEASE; DISEASE COURSE; ENTERIC FEEDING; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; INFECTIOUS DIARRHEA; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; IRRITABLE COLON; METAGENOMICS; MICROBIAL COLONIZATION; MICROBIAL DIVERSITY; MICROBIAL POPULATION DYNAMICS; NECROTIZING ENTEROCOLITIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPECIES HABITAT; DIARRHEA; ENTEROCOLITIS, NECROTIZING; HOST PATHOGEN INTERACTION; HYPERSENSITIVITY; INFLAMMATORY BOWEL DISEASES; INTESTINE; IRRITABLE BOWEL SYNDROME; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; SYMBIOSIS;

DIARRHEA; ENTEROCOLITIS, NECROTIZING; GASTROINTESTINAL MICROBIOME; HOST-PATHOGEN INTERACTIONS; HUMANS; HYPERSENSITIVITY; INFLAMMATORY BOWEL DISEASES; INTESTINES; IRRITABLE BOWEL SYNDROME; PROBIOTICS; SYMBIOSIS;

EID: 84979076129     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-3-319-31248-4_8     Document Type: Chapter

References (86)

1. Al-Abri SS, Beeching NJ, Nye FJ (2005) Traveller’s diarrhoea. Lancet Infect Dis 5:349–360
2. Alfaleh K, Anabrees J (2014) Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 4:CD005496
3. Azad MB, Coneys JG, Kozyrskyj AL, Field CJ, Ramsey CD, Becker AB, Friesen C, Abou-Setta AM, Zarychanski R (2013) Probiotic supplementation during pregnancy or infancy for the prevention of asthma and wheeze: systematic review and meta-analysis. BMJ 347:f6471
4. Bager P, Wohlfahrt J, Westergaard T (2008) Caesarean delivery and risk of atopy and allergic disease: metaanalyses. Clin Exp Allergy 38:634–642
5. Bartlett JG (2002) Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 346:334–339
6. Bouma G, Strober W (2003) The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 3:521–533
7. Boyle RJ, Bath-Hextall FJ, Leonardi-Bee J, Murrell DF, Tang ML-K (2009) Probiotics for the treatment of eczema: a systematic review. Clin Exp Allergy 39:1117–1127
8. Brenner DM, Moeller MJ, Chey WD, Schoenfeld PS (2009) The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review. Am J Gastroenterol 104:1033–1049, quiz 1050
9. Bron PA, van Baarlen P, Kleerebezem M (2012) Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa. Nat Rev Microbiol 10:66–78
10. Brooks C, Pearce N, Douwes J (2013) The hygiene hypothesis in allergy and asthma: an update. Curr Opin Allergy Clin Immunol 13:70–77
11. Brotman RM (2011) Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective. J Clin Invest 121:4610–4617
12. Buffie CG, Pamer EG (2013) Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol 13:790–801
13. Carlisle EM, Morowitz MJ (2013) The intestinal microbiome and necrotizing enterocolitis. Curr Opin Pediatr 25:382–387
14. Chang JY, Talley NJ (2011) An update on irritable bowel syndrome: from diagnosis to emerging therapies. Curr Opin Gastroenterol 27:72–78
15. Cho JH (2008) The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol 8:458–466
16. Deshpande G, Rao S, Patole S, Bulsara M (2010) Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 125:921–930
17. Dethlefsen L, Relman DA (2011) Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A 108(Suppl):4554–4561
18. Dinan TG, Cryan JF (2013) Melancholic microbes: a link between gut microbiota and depression? Neurogastroenterol Motil 25:713–719
19. Doege K, Grajecki D, Zyriax B-C, Detinkina E, Zu Eulenburg C, Buhling KJ (2012) Impact of maternal supplementation with probiotics during pregnancy on atopic eczema in childhood – a meta-analysis. Br J Nutr 107:1–6
20. Doherty G, Bennett G, Patil S, Cheifetz A, Moss AC (2009) Interventions for prevention of post-operative recurrence of Crohn’s disease. Cochrane Database Syst Rev 7:CD006873
21. Doherty GA, Bennett GC, Cheifetz AS, Moss AC (2010) Meta-analysis: targeting the intestinal microbiota in prophylaxis for post-operative Crohn’s disease. Aliment Pharmacol Ther 31:802–809
22. DuPont HL (2014) Acute infectious diarrhea in immunocompetent adults. N Engl J Med 370:1532–1540
23. Elazab N, Mendy A, Gasana J, Vieira ER, Quizon A, Forno E (2013) Probiotic administration in early life, atopy, and asthma: a meta-analysis of clinical trials. Pediatrics 132:e666–e676
24. Faith JJ, Guruge JL, Charbonneau M, Subramanian S, Seedorf H, Goodman AL, Clemente JC, Knight R, Heath AC, Leibel RL, Rosenbaum M, Gordon JI (2013) The long-term stability of the human gut microbiota. Science 341:1237439
25. FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics (2002) Guidelines for the evaluation of probiotics in food
26. Foligné B, Daniel C, Pot B (2013) Probiotics from research to market: the possibilities, risks and challenges. Curr Opin Microbiol 16:284–292
27. Franks AH, Harmsen HJ, Raangs GC, Jansen GJ, Schut F, Welling GW (1998) Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol 64:3336–3345
28. Gajer P, Brotman RM, Bai G, Sakamoto J, Schütte UME, Zhong X, Koenig SSK, Fu L, Ma ZS, Zhou X, Abdo Z, Forney LJ, Ravel J (2012) Temporal dynamics of the human vaginal microbiota. Sci Transl Med 4:132ra52
29. Gareau MG, Sherman PM, Walker WA (2010) Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol 7:503–514
30. Gephart SM, McGrath JM, Effken JA, Halpern MD (2012) Necrotizing enterocolitis risk: state of the science. Adv Neonatal Care 12:77–87, quiz 88–9
31. Gerritsen J, Smidt H, Rijkers GT, de Vos WM (2011) Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr 6:209–240
32. Gevers D, Kugathasan S, Denson LA, Vázquez-Baeza Y, Van Treuren W, Ren B, Schwager E, Knights D, Song SJ, Yassour M, Morgan XC, Kostic AD, Luo C, González A, McDonald D, Haberman Y, Walters T, Baker S, Rosh J, Stephens M, Heyman M, Markowitz J, Baldassano R, Griffiths A, Sylvester F, Mack D, Kim S, Crandall W, Hyams J, Huttenhower C, Knight R, Xavier RJ (2014) The treatment-naive microbiome in new-onset Crohn’s disease. Cell Host Microbe 15:382–392
33. Goldenberg JZ, Ma SSY, Saxton JD, Martzen MR, Vandvik PO, Thorlund K, Guyatt GH, Johnston BC (2013) Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev 5:CD006095
34. Grice EA, Segre JA (2011) The skin microbiome. Nat Rev Microbiol 9:244–253
35. Grishin A, Papillon S, Bell B, Wang J, Ford HR (2013) The role of the intestinal microbiota in the pathogenesis of necrotizing enterocolitis. Semin Pediatr Surg 22:69–75
36. Hempel S, Newberry SJ, Maher AR, Wang Z, Miles JNV, Shanman R, Johnsen B, Shekelle PG (2012) Probiotics for the prevention and treatment of antibioticassociated diarrhea: a systematic review and metaanalysis. JAMA 307:1959–1969
37. Holubar SD, Cima RR, Sandborn WJ, Pardi DS (2010) Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis. Cochrane Database Syst Rev 16:CD001176
38. Hoveyda N, Heneghan C, Mahtani KR, Perera R, Roberts N, Glasziou P (2009) A systematic review and metaanalysis: probiotics in the treatment of irritable bowel syndrome. BMC Gastroenterol 9:15
39. Human Microbiome Project Consortium (2012) Structure, function and diversity of the healthy human microbiome. Nature 486:207–214
40. Jeffery IB, O’Toole PW, Öhman L, Claesson MJ, Deane J, Quigley EMM, Simrén M (2012) An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut 61:997–1006
41. Jin MS, Kim SE, Heo JY, Lee ME, Kim HM, Paik S-G, Lee H, Lee J-O (2007) Crystal structure of the TLR1- TLR2 heterodimer induced by binding of a triacylated lipopeptide. Cell 130:1071–1082
42. Johnson S, Maziade P-J, McFarland LV, Trick W, Donskey C, Currie B, Low DE, Goldstein EJC (2012) Is primary prevention of Clostridium difficile infection pos- sible with specific probiotics? Int J Infect Dis 16:e786–e792
43. Johnston BC, Goldenberg JZ, Vandvik PO, Sun X, Guyatt GH (2011) Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev 29(2):232–42 CD004827
44. Johnston BC, Ma SSY, Goldenberg JZ, Thorlund K, Vandvik PO, Loeb M, Guyatt GH (2012) Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Ann Intern Med 157:878–888
45. Joossens M, Huys G, Cnockaert M, De Preter V, Verbeke K, Rutgeerts P, Vandamme P, Vermeire S (2011) Dysbiosis of the faecal microbiota in patients with Crohn’s disease and their unaffected relatives. Gut 60:631–637
46. Kay AB (2000) Overview of “allergy and allergic diseases: with a view to the future”. Br Med Bull 56:843–864
47. Kerckhoffs APM, Samsom M, van der Rest ME, de Vogel J, Knol J, Ben-Amor K, Akkermans LMA (2009) Lower Bifidobacteria counts in both duodenal mucosaassociated and fecal microbiota in irritable bowel syndrome patients. World J Gastroenterol WJG 15:2887–2892
48. Kostic AD, Xavier RJ, Gevers D (2014) The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology 146:1489–1499
49. Lilly DM, Stillwell RH (1965) Probiotics: growthpromoting factors produced by microorganisms. Science 147:747–748
50. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC (2006) Functional bowel disorders. Gastroenterology 130:1480–1491
51. Ma B, Forney LJ, Ravel J (2012) Vaginal microbiome: rethinking health and disease. Annu Rev Microbiol 66:371–389
52. Matamoros S, Gras-Leguen C, Le Vacon F, Potel G, de La Cochetiere M-F (2013) Development of intestinal microbiota in infants and its impact on health. Trends Microbiol 21:167–173
53. McFarland LV, Dublin S (2008) Meta-analysis of probiotics for the treatment of irritable bowel syndrome. World J Gastroenterol 14:2650–2661
54. Mihatsch WA, Braegger CP, Decsi T, Kolacek S, Lanzinger H, Mayer B, Moreno LA, Pohlandt F, Puntis J, Shamir R, Stadtmüller U, Szajewska H, Turck D, van Goudoever JB (2012) Critical systematic review of the level of evidence for routine use of probiotics for reduction of mortality and prevention of necrotizing enterocolitis and sepsis in preterm infants. Clin Nutr 31:6–15
55. Moayyedi P, Ford AC, Talley NJ, Cremonini F, Foxx- Orenstein AE, Brandt LJ, Quigley EMM (2010) The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 59:325–332
56. Neu J, Walker WA (2011) Necrotizing enterocolitis. N Engl J Med 364:255–264
57. Panduru M, Panduru NM, Sălăvăstru CM, Tiplica G-S (2014) Probiotics and primary prevention of atopic dermatitis: a meta-analysis of randomized controlled studies. J Eur Acad Dermatol Venereol 29:232–42
58. Pérez-Cobas AE, Artacho A, Knecht H, Ferrús ML, Friedrichs A, Ott SJ, Moya A, Latorre A, Gosalbes MJ (2013) Differential effects of antibiotic therapy on the structure and function of human gut microbiota. PLoS One 8:e80201
59. Peterson DA, Frank DN, Pace NR, Gordon JI (2008) Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. Cell Host Microbe 3:417–427
60. Pihlstrom BL, Michalowicz BS, Johnson NW (2005) Periodontal diseases. Lancet 366:1809–1820
61. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto J-M, Hansen T, Le Paslier D, Linneberg A, Nielsen HB, Pelletier E, Renault P, Sicheritz-Ponten T, Turner K, Zhu H, Yu C, Li S, Jian M, Zhou Y, Li Y, Zhang X, Li S, Qin N, Yang H, Wang J, Brunak S, Doré J, Guarner F, Kristiansen K, Pedersen O, Parkhill J, Weissenbach J, Bork P, Ehrlich SD, Wang J (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464:59–65
62. Rajilić-Stojanović M, Biagi E, Heilig HGHJ, Kajander K, Kekkonen RA, Tims S, de Vos WM (2011) Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 141:1792–1801
63. Rigsbee L, Agans R, Shankar V, Kenche H, Khamis HJ, Michail S, Paliy O (2012) Quantitative profiling of gut microbiota of children with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol 107:1740–1751
64. Ritchie ML, Romanuk TN (2012) A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLoS One 7:e34938
65. Russell SL, Finlay BB (2012) The impact of gut microbes in allergic diseases. Curr Opin Gastroenterol 28:563–569
66. Sang L-X, Chang B, Zhang W-L, Wu X-M, Li X-H, Jiang M (2010) Remission induction and maintenance effect of probiotics on ulcerative colitis: a meta-analysis. World J Gastroenterol 16:1908–1915
67. Schwabe RF, Jobin C (2013) The microbiome and cancer. Nat Rev Cancer 13:800–812
68. Schwiertz A, Jacobi M, Frick J-S, Richter M, Rusch K, Köhler H (2010) Microbiota in pediatric inflammatory bowel disease. J Pediatr 157:240–244.e1
69. Sears CL, Garrett WS (2014) Microbes, microbiota, and colon cancer. Cell Host Microbe 15:317–328
70. Sekirov I, Russell SL, Antunes LCM, Finlay BB (2010) Gut microbiota in health and disease. Physiol Rev 90:859–904
71. Shen J, Zuo Z-X, Mao A-P (2014) Effect of probiotics on inducing remission and maintaining therapy in ulcer- ative colitis, Crohn’s disease, and pouchitis: meta- analysis of randomized controlled trials. Inflamm Bowel Dis 20:21–35
72. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez- Humarán LG, Gratadoux J-J, Blugeon S, Bridonneau C, Furet J-P, Corthier G, Grangette C, Vasquez N, Pochart P, Trugnan G, Thomas G, Blottière HM, Doré J, Marteau P, Seksik P, Langella P (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 105:16731–16736
73. Sommer F, Bäckhed F (2013) The gut microbiota – masters of host development and physiology. Nat Rev Microbiol 11:227–238
74. Stecher B, Hardt W-D (2008) The role of microbiota in infectious disease. Trends Microbiol 16:107–114
75. Thielman NM, Guerrant RL (2004) Clinical practice. Acute infectious diarrhea. N Engl J Med 350:38–47
76. Ubeda C, Pamer EG (2012) Antibiotics, microbiota, and immune defense. Trends Immunol 33:459–466
77. Van Loo ES, Dijkstra G, Ploeg RJ, Nieuwenhuijs VB (2012) Prevention of postoperative recurrence of Crohn’s disease. J Crohns Colitis 6:637–646
78. Videlock EJ, Cremonini F (2012) Meta-analysis: probiotics in antibiotic-associated diarrhoea. Aliment Pharmacol Ther 35:1355–1369
79. Wang J, Qi J, Zhao H, He S, Zhang Y, Wei S, Zhao F (2013) Metagenomic sequencing reveals microbiota and its functional potential associated with periodontal disease. Sci Rep 3:1843
80. Whelan K (2011) Probiotics and prebiotics in the management of irritable bowel syndrome: a review of recent clinical trials and systematic reviews. Curr Opin Clin Nutr Metab Care 14:581–587
81. Whelan K, Quigley EMM (2013) Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease. Curr Opin Gastroenterol 29:184–189
82. WHO (Fact Sheet No. 330, April 2013) Diarrhoeal disease. World Health Organization. http://www.who.int/ mediacentre/factsheets/fs330/en/
83. Wills-Karp M, Santeliz J, Karp CL (2001) The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol 1:69–75
84. Xavier RJ, Podolsky DK (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448:427–434
85. Yang YW, Tsai CL, Lu CY (2009) Exclusive breastfeeding and incident atopic dermatitis in childhood: a systematic review and meta-analysis of prospective cohort studies. Br J Dermatol 161:373–383
86. Zeeuwen PLJM, Kleerebezem M, Timmerman HM, Schalkwijk J (2013) Microbiome and skin diseases. Curr Opin Allergy Clin Immunol 13:514–520